Zusammenfassung
Die Koronardurchblutung wird unter physiologischen und pathophysiologischen Bedingungen durch die vorgegebene Geometrie des koronaren Gefäßbaumes sowie durch mechanische, metabolische, endotheliale, humorale und neuronale Faktoren bestimmt.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Abdelmeguid AE, Fehler JH (1994) Effect of low perfusate [Ca21 and diltiazem on cardiac sarcoplasmic reticulum in myocardial stunning. Am J Physiol 266:H406–H414
Albro PC, Gould KL, Westcott RJ, Hamilton GW, Ritchie JL, Williams DL (1978) Noninvasive assessment of coronary stenoses by myocardial imaging during pharmacologic coronary vasodilation. III. Clinical trial. Am J Cardiol 42: 751–760
Alps BJ, Calder C, Wilson A (1983) The beneficial effect of nicardipine compared with nifedipine and verapamil in limiting myocardial infarct size in baboons. Drug Res 33: 868876
Alps BJ, Calder C, Wilson A, Scott-Park FM (1983) The beneficial effect of nicardipine on the healing of myocardial infarcts in dogs. Drug Res 33: 1638–1646
Altman J, Dulas D, Bache RJ (1992) Effect of cyclooxigenase blockade on blood flow through well-developed coronary collateral vessels. Circ Res 70: 1091–1098
Ambrosio G, Jacobus WE, Bergmann CA, Weisman HF, Becker LC (1987) Pre-served high energy phosphate metabolic reserve in globally stunned hearts despite reduction of basal ATP content and contractility. J Mol Cell Cardiol 19: 953–964
Amende I, Bentivegna LA, Zeind AJ, Wenzlaff P, Grossman W, Morgan JP (1992) Intracellular calcium and ventricular function. Effects of nisoldipine on global ischemia in the isovolumic, coronary-perfused heart. J Clin Invest 89: 2060–2065
Anversa P, Loud AV, Levicky V, Guideri G (1985) Left ventricular failure induced by myocardial infarction: I. myocyte hypertrophy. Am J Physiol 248:H876–H882
Armstrong S, Downey JM, Ganote CE (1994) Preconditioning of isolated rabbit cardiomyocytes: induction by metabolic stress and blockade by the adenosine antagonist SPT and calphostin C, a protein kinase C inhibitor. Cardiovasc Res 28: 72–77
Arnold JMO, Braunwald E, Sandor T, Kloner RA (1985) Inotropic stimulation of reperfused myocardium with dopamine: effects on infarct size and myocardial function. J Am Coll Cardiol 6: 1036–1044
Austin RE, Aldea GS, Coggins DL, Flynn AE, Hoffman JIE (1990) Profound spatial heterogeneity of coronary reserve. Discordance between patterns of resting and maximal myocardial blood flow. Circ Res 67: 319–331
Aversano T, Becker LC (1985) Persistence of coronary vasodilator reserve despite functionally significant flow reduction. Am J Physiol 248: H403–H411
Bache RJ, Cobb FR (1977) Effect of maximal coronary vasodilation on transmural myocardial perfusion during tachycardia in the awake dog. Circ Res 41: 648–653
Bassenge E, Heusch G (1990) Endothelial and neuro-humoral control of coronary blood flow in health and disease. Rev Physiol Biochem Pharmacol 116: 77–165
Bassenge E, Walter P, Doutheil U (1967) Wirkungsumkehr der adrenergischen Coronargefässreaktion in Abhängigkeit vom Coronargefässtonus. Pfluegers Arch 297: 146–155
Baumgart D, Ehring T, Kowallik P, Guth BD, Krajcar M, Heusch G (1993) The impact of a-adrenergic coronary vasoconstriction on the transmural myocardial blood flow distribution during humoral and neuronal adrenergic activation. Circ Res 73: 869–886
Baumgart D, Ehring T, Krajcar M, Heusch G (1993) A proischemic effect of nisoldipine: Relation to a decrease in perfusion pressure and comparison to dipyridamole. Cardiovasc Res 27: 1254–1259
Bean BP (1984) Nitrendipine block of cardiac calcium channels: High-affinity binding to the inactivated state. Proc Natl Acad Sci USA 81: 6388–6392
Becker LC, Levine JH, DiPaula AF, Guarnieri T, Aversano T (1986) Reversal of dysfunction in postischemic stunned myocardium by epinephrine and postextrasystolic potentiation. J Am Coll Cardiol 7: 580–589
Belloni FL, Bruttig SP, Rubio R, Berne RM (1986) Uptake and release of adenosine by cultured rat aortic smooth muscle. Microvasc Res 32: 200–210
Berne RM (1958) Effect of epinephrine and norepinephrine on coronary circulation. Circ Res 6: 644–655
Berne RM (1963) Cardiac nucleotides in hypoxia: possible role in regulation of coronary blood flow. Am J Physiol 204: 317–322
Berne RM, Blackmon JR, Gardner TH (1957) Hypoxemia and coronary blood flow. J Clin Invest 36: 1101–1106
Berne RM, DeGeest H, Levy MN (1965) Influence of the cardiac nerves on coronary resistance. Am J Physiol 208: 763–769
Bolli R (1990) Mechanism of myocardial „stunning“. Circulation 82: 723–738
Bolli R (1991) Oxygen-derived free radicals and myocardial reperfusion injury: An Overview. Cardiovasc Drugs Ther 5: 249–268
Bolli R (1992) Myocardial „Stunning“in man. Circulation 86: 1671–1691
Bolli R, Jeroudi MO, Patel BS, Aruoma OI, Halliwell B, Lai EK, McCay PB (1989) Marked reduction of free radical generation and contractile dysfunction by antioxidant therapy begun at the time of reperfusion. Evidence that myocardial „stunning“ is a manifestation of reperfusion injury. Circ Res 65: 607–622
Bolli R, Jeroudi MO, Patel BS, DuBose CM, Lai EK, Roberts R, McCay PB (1989) Direct evidence that oxygen-derived free radicals contribute to postischemic myocardial dysfunction in the intact dog. Proc Natl Acad Sci USA 86: 4695–4699
Bolli R, Patel BS, Jeroudi MO, Lai EK, McCay PB (1988) Demonstration of free radical generation in „stunned“ myocardium of intact dogs with the use of the spin trap a-phenyl N-tert-butyl nitrone. J Clin Invest 82: 476–485
Bolli R, Triana JF, Jeroudi MO (1990) Prolonged impairment of coronary vasodilation after reversible ischemia. Circ Res 67: 332–343
Bolli R, Zhu W-X, Hartley CJ, Michael LH, Repine JE, Hess ML, Kukreja RC, Roberts R (1987) Attenuation of dysfunction in the postischemic „stunned“ myocardium by dimethylthiourea. Circulation 76: 458–468
Bolli R, Zhu W-X, Thornby JI, O’Neill PG, Roberts R (1988) Time course and determinants of recovery of function after reversible ischemia in conscious dogs. Am J Physiol 254:H102–H114
Boström S-L, Ljung B, Mardh S, Forsen S, Thulin E (1981) Interaction of the antihypertensive drug felodipine with calmodulin. Nature 292: 777–778
Braunwald E, Kloner RA (1982) The stunned myocardium: prolonged, postischemic ventricular dysfunction. Circulation 66: 1146–1149
Braunwald E, Sobel BE (1988) Coronary blood flow and myocardial ischemia. In: Braunwald, E (Ed) Heart Disease. A textbook of cardiovascular medicine. W.B. Saunders Company, Philadelphia, pp 1201–1203
Bretschneider HJ (1971) Die haemodynamischen Determinanten des O2-Bedarfes des Herzmuskels. Drug Res 21: 1515–1517
Broten TP, Romson JL, Fullerton DA, van Winkle DM, Feigl EO (1991) Synergistic action of myocardial oxygen and carbon dioxide in controlling coronary blood flow. Circ Res 68: 531–542
Brown BG, Lee AB, Bolson EL, Dodge HT (1984) Reflex constriction of significant coronary stenosis as a mechanism contributing to ischemic left ventricular dysfunction during isometric exercise. Circulation 70: 18–24
Buckberg GD, Fixler DE, Archie Jr. JP, Hoffman JIE (1972) Experimental subendocardial ischemia in dogs with normal coronary arteries. Circ Res 30: 67–81
Buffington CW, Feigl EO (1981) Adrenergic coronary vasoconstriction in the presence of coronary stenosis in the dog. Circ Res 48: 416–423
Bush LR, Romson JL, Ash JL, Lucchesi BR (1982) Effects of diltiazem on extent of ultimate myocardial injury resulting from temporary coronary artery occlusion in dogs. J Cardiovase Pharmacol 4: 285–296
Buss DD, Wüsten B, Schaper W (1978) Effects of coronary stenoses and ventricular loading conditions on coronary flow. Basic Res Cardiol 73: 571–583
Bussmann W-D, Seher W, Gruengras M (1984) Reduction of creatine kinase and creatine kinase-MB indexes of infarct size by intravenous verapamil. Am J Cardiol 54: 1224–1230
Canty JM (1988) Coronary pressure-function and steady-state pressure-flow relations during autoregulation in the unanesthetized dog. Circ Res 63: 821–836
Canty JM, Klocke FJ (1985) Reduced regional myocardial perfusion in the presence of pharmacologic vasodilator reserve. Circulation 71: 370–377
Carrozza Jr. JP, Bentivegna LA, Williams CP, Kuntz RE, Grossman W, Morgan JP (1992) Decreased myofilament responsiveness in myocardial stunning follows transient calcium overload during ischemia and reperfusion. Circ Res 71: 1334–1340
Chakravati RN, Sharma PL, Anand IS, Alamelu Manga P, Wahi PL (1981) Effect of verapamil (isoptin) on experimental myocardial infarction in rhesus monkeys. Indian J Med Res 73: 625–632
Chierchia S, Davies G, Berkenboom G, Crea F, Crean P, Maseri A (1984) a-Adrenergic receptors and coronary spasm: an elusive link. Circulation 69:8–14
Chilian WM (1991) Functional distribution of a 1 -and az-adrenergic receptors in the coronary microcirculation. Circulation 84: 2108–2122
Chilian WM, Layne SM, Eastham CL, Marcus ML (1989) Heterogeneous microvascular coronary a-adrenergic vasoconstriction. Circ Res 64: 376–388
Chilian WM, Layne SM, Klausner EC, Eastham CL, Marcus ML (1989) Redistribution of coronary microvascular resistance produced by dipyridamole. Am J Physiol 256: H383–H390
Chu A, Morris K, Kuehl W, Cusma J, Navetta F, Cobb FR (1989) Effects of atrial natriuretic peptide on the coronary arterial vasculature in humans. Circulation 80: 1627–1635
Clozel J-P, Clozel M (1989) Effects of endothelin on the coronary vascular bed in open-chest dogs. Circ Res 65: 1193–1200
Cocks TM, Angus JA (1983) Endothelium-dependent relaxation of coronary arteries by noradrenaline and serotonin. Nature 305: 627–629
Cohen MV, Kirk ES (1973) Differential response of large and small coronary arteries to nitroglycerin and angiotensin. Circ Res 33: 445–453
Crossman DC, Larkin SW, Fuller RW, Davies GJ, Maseri A (1989) Substance P dilates epicardial coronary arteries and increases coronary blood flow in humans. Circulation 80: 475–484
Crottogini AJ, Depaoli JR, Barra JG, Fischer EC, Chatruc MR, Pichel RH, de la Fuente L (1985) The effect of the new calcium antagonist nisoldipine (BAY k-5552) on myocardial infarct size limitation in conscious dogs. Am Heart J 110: 753–760
Dai X-Z, Bache RJ (1984) Effect of indomethacin on coronary blood flow during graded treadmill exercise in the dog. Am J Physiol 247:H452–H458
Danish Multicenter Study Group on Verapamil in Myocardial Infarction (1984) Verapamil in acute myocardial infarction. Am J Cardiol 54:24E–28E
de Jong JW (1985) Timely administration of nisoldipine is essential for prevention of myocardial ATP catabolism. Eur J Pharmacol 118: 53–59
DeBoer LWV, Strauss HW, Kloner RA (1980) Autoradiographic method for measuring the ischemic myocardium at risk: verapamil on infarct size after experimental coronary artery occlusion. Proc Natl Acad Sci USA 77: 6119–6123
Deussen A, Lloyd HGE, Schrader J (1989) Contribution of S-adenosylhomocysteine to cardiac adenosine formation. J Mol Cell Cardiol 21: 773–782
Deussen A, Möser G, Schrader J (1986) Contribution of coronary endothelial cells to cardiac adenosine production. Pfluegers Arch 406: 608–614
Deutsch E, Berger M, Kussmaul WG, Hirshfeld Jr. JW, Herrmann HC, Laskey WK (1990) Adaptation to ischemia during percutaneous transluminal coronary angioplasty. Clinical, hemodynamic, and metabolic features. Circulation 82: 2044–2051
DeWitt DF, Wangler RD, Thompson CI, Sparks Jr. HV (1983) Phasic release of adenosine during steady state metabolic stimulation in the isolated guinea pig heart. Circ Res 53: 636643
Dole WP (1987) Autoregulation of the coronary circulation. Prog Cardiovasc Dis 29: 293323
Dole WP, Nuno DW (1986) Myocardial oxygen tension determines the degree and pressure range of coronary autoregulation. Circ Res 59: 202–215
Dole WP, Yamada N, Bishop VS, Olsson RA (1985) Role of adenosine in coronary blood flow regulation after reductions in perfusion pressure. Circ Res 56: 517–524
Downey JM, Kirk ES (1975) Inhibition of coronary blood flow by a vascular waterfall mechanism. Circ Res 36: 753–760
Drexler H, Zeiher AM, Wollschläger H, Meinertz T, Just H, Bonzel T (1989) Flow-dependent coronary artery dilatation in humans. Circulation 80: 466–474
Du Toit EF, Opie LH (1992) Modulation of severity of reperfusion stunning in the isolated rat heart by agents altering calcium flux at the onset of reperfusion. Circ Res 70: 960–967
Dunlap ED, Matlib MA, Millard RW (1989) Protection of regional mechanics and mitochondrial oxidative phosphorylation by amlodipine in transiently ischemic myocardium. Am J Cardiol 64:84 I-93 I.
Ehring T, Baumgart D, Krajcar M, Hümmelgen M, Kompa S, Heusch G (1994) Attenuation of myocardial stunning by the ACE-inhibitor ramiprilat through a signal cascade of bradykinin and prostaglandins, but not nitric oxide. Circulation 90: 1368–1385
Ehring T, Böhm M, Heusch G (1992) The calcium antagonist nisoldipine improves the functional recovery of reperfused myocardium only when given before ischemia. J Cardiovasc Pharmacol 20: 63–74
Ehring T, Heusch G (1990) Felodipine prevents the poststenotic myocardial ischemia induced by a2-adrenergic coronary constriction. Cardiovasc Drugs Ther 4: 443–449
Ehring T, Heusch G (1991) Postextrasystolic potentiation does not distinguish ischaemic from stunned myocardium. Pfluegers Arch 418: 453–461
Ehring T, Krajcar M, Baumgart D, Kompa S, Hömmelgen M, Heusch G (1995) Cholinergic and a-adrenergic coronary vasomotion with increasing ischemia-reperfusion injury. Am J Physiol 268:H886–H894
Ellis SG, Wynne J, Braunwald E, Henschke CI, Sandor T, Kloner RA (1984) Response of reperfusion-salvaged, stunned myocardium to inotropic stimulation. Am Heart J 107: 1319
Ertl G (1987) Coronary vasoconstriction in experimental myocardial ischemia. J Cardiovasc Pharmacol 9 (Supp1.2):S9–S17
Ertl G, Simm F, Wichmann J, Fuchs M, Lochner W (1979) The dependence of coronary collateral blood flow on regional vascular resistances. Naunyn Schmiedebergs Arch Pharmacol 308: 265–272
Evans RG, Val-Mejias J, Fischer VW, Mueller HS (1985) Evaluation of a rat model for assessing interventions to salvage ischaemic myocardium: effects of ibuprofen and verapamil. Cardiovasc Res 19: 132–138
Evers AS, Murphree S, Saffitz JE, Jakschik BA, Needleman P (1985) Effects of endogenously produced leukotrienes, thromboxane, and prostaglandins on coronary vascular resistance in rabbit myocardial infarction. J Clin Invest 75: 992–999
Fam WM, McGregor M (1968) Effect of nitroglycerin and dipyridamole on regional coronary resistance. Circ Res 22: 649–659
Faria DB, Goncalves FR, Maroko PR (1990) Three-dimensional analysis of infarct size reduction after administration of gallopamil in dogs. Drug Res 40: 19–23
Fauler J, Frölich JC (1989) Cardiovascular effects of leukotrienes. Cardiovasc Drugs Ther 3: 499–505
Fedele FA, Gewirtz H, Capone RJ, Sharaf B, Most AS (1988) Metabolic response to prolonged reduction of myocardial blood flow distal to a severe coronary artery stenosis. Circulation 78: 729–735
Feigl EO (1969) Parasympathetic control of coronary blood flow in dogs. Circ Res 25: 509519
Feigl EO (1975) Control of myocardial oxygen tension by sympathetic coronary vasoconstriction in the dog. Circ Res 37: 88–95
Figueredo VM, Brandes R, Weiner MW, Massie BM, Camacho SA (1992) Cardiac contractile dysfunction during mild coronary flow reductions is due to an altered calcium-pressure relationship in rat hearts. J Clin Invest 90: 1794–1802
Fleckenstein A (1983) History of calcium antagonists. Circ Res 52 (Suppl.I): 3–16
Fleckenstein A, Fleckenstein-Grün G (1988) Mechanism of action of calcium antagonists in heart and vascular smooth muscle. Eur Heart J 9 (Suppl. H): 95–99
Fleckenstein-Grün G (1992) Gallopamil: Cardiovascular scope of action of a highly specific calcium antagonist. J Cardiovasc Pharmacol 20 (Suppl. 7):S1–S10
Foster E, de Jong D, Connelly C, Apstein CS (1984) Failure of nifedipine and reperfusion to reduce infarct size relative to region at risk as measured by NADH fluorophotography. Circulation 70: 506–512
Förstermann U, Mülsch A, Böhme E, Busse R (1986) Stimulation of soluble guanylate cyclase by an acetylcholine-induced endothelium-derived factor from rabbit and canine arteries. Circ Res 58: 531–538
Fujibayashi Y, Yamazaki S, Chang B-L, Rajagopalan RE, Meerbaum S, Corday E (1985) Comparative echocardiographic study of recovery of diastolic versus systolic function after brief periods of coronary occlusion: differential effects of intravenous nifedipine administered before and during occlusion. J Am Coll Cardiol 6: 1289–1298
Furchgott RF, Zawadzki JV (1980) The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288: 373–376
Gage JE, Hess OM, Murakami T, Ritter M, Grimm J, Krayenbuehl HP (1986) Vasoconstriction of stenotic coronary arteries during dynamic exercise in patients with classic angina pectoris: reversibility by nitroglycerin. Circulation 73: 865–876
Gallagher KP, Folts JD, Shebuski RJ, Rankin JHG, Rowe GG (1980) Subepicardial vasodilator reserve in the presence of critical coronary stenosis in dogs. Am J Cardiol 46: 6773
Gallagher KP, Matsuzaki M, Osakada G, Kemper WS, Ross Jr. J (1983) Effect of exercise on the relationship between myocardial blood flow and systolic wall thickening in dogs with acute coronary stenosis. Circ Res 52: 716–729
Garcia-Dorado D, Thèroux P, Fernandez-Aviles F, Elizaga J, Solares J, Galinanes M (1987) Diltiazem and progression of myocardial ischemic damage during coronary artery occlusion and reperfusion in porcine hearts. J Am Coll Cardiol 10: 906–911
Gaudron P, Blumrich M, Ertl G (1993) Aggravation of left ventricular dilatation and reduction of survival by a calcium channel blocker in rats with chronic myocardial infarction. Am Heart J 125: 1226–1233
Geary GG, Smith GT, Suehiro GT, McNamara JJ (1982) Failure of nifedipine therapy to reduce myocardial infarct size. Am J Cardiol 49: 331–338
Gerlach E, Deuticke B, Dreisbach RH (1963) Der Nucleotid-Abbau im Herzmuskel bei Sauerstoffmangel and seine mögliche Bedeutung für die Coronardurchblutung. Naturwissenschaften 6: 228–229
Gewirtz H, Weeks G, Nathanson M, Sharaf B, Fedele F, Most AS (1989) Tissue acidosis. Role in sustained arteriolar dilatation distal to a coronary stenosis. Circulation 79: 890898
Go LO, Moschella MC, Watras J, Handa KK, Fyfe BS, Marks AR (1995) Differential regulation of two types of intracellular calcium release channels during end-stage heart failure. J Clin Invest 95: 888–894
Godfraind T, Egléme C, Finet M, Jaumin P (1987) The actions of nifedipine and nisoldipine on the contractile activity of human coronary arteries and human cardiac tissue in vitro. Pharmacol Toxicol 61: 79–84
Godfraind T, Miller R, Wibo M (1986) Calcium antagonism and calcium entry blockade. Pharmacol Rev 38: 321–416
Gorman MW, Sparks HVJ (1982) Progressive coronary vasoconstriction during relative ischemia in canine myocardium. Circ Res 51: 411–420
Gould KL (1978) Noninvasive assessment of coronary stenoses by myocardial perfusion imaging during pharmacologic coronary vasodilation. I. Physiologic basis and experimental validation. Am J Cardiol 41: 267–278
Gould KL (1980) Dynamic coronary stenosis. Am J Cardiol 45: 286–292
Gould KL, Lipscomb K (1974) Effects of coronary stenoses on coronary flow reserve and resistance. Am J Cardiol 34: 48–55
Görge G, Papageorgiou I, Lerch R (1990) Epinephrine-stimulated contractile and metabolic reserve in postischemic rat myocardium. Basic Res Cardiol 85: 595–605
Gross GJ, Auchampach JA (1992) Blockade of ATP-sensitive potassium channels prevents myocardial preconditioning in dogs. Circ Res 70: 223–233
Gross GJ, Farber NE, Hardman HF, Warltier DC (1986) Beneficial actions of superoxide dismutase and catalase in stunned myocardium of dogs. Am J Physiol 250: H372–H377
Gross GJ, Pieper GM (1992) Beneficial actions of amlodipine in the multiple-stunned canine myocardium. Cardiovasc Drugs Ther 6: 67–75
Gross GJ, Warltier DC, Hardman HF (1987) Comparative effects of nicorandil, a nicotinamide nitrate derivative, and nifedipine on myocardial reperfusion injury in dogs. J Cardiovase Pharmacol 10: 535–542
Guarnieri T (1989) Direct measurement of [Ca2+1; in early and late reperfused myocardium. Circulation 80 (Suppl.II):II-241(Abstract)
Guth BD, Heusch G, Seitelberger R, Ross Jr. J (1987) Elimination of exercise-induced regional myocardial dysfunction by a bradycardic agent in dogs with chronic coronary stenosis. Circulation 75: 661–669
Guth BD, Heusch G, Seitelberger R, Ross Jr. J (1987) Mechanism of beneficial effect of beta-adrenergic blockade on exercise-induced myocardial ischemia in conscious dogs. Circ Res 60: 738–746
Guth BD, Schulz R, Heusch G (1991) Pressure-flow characteristics in the right and left ventricular perfusion territories of the right coronary artery in swine. Pfluegers Arch 419: 622–628
Guth BD, Schulz R, Heusch G (1993) Time course and mechanisms of contractile dysfunction during acute myocardial ischemia. Circulation 87 (Suppl.IV):IV-35-IV-42
Guyton RA, McClenathan JH, Newman GE, Michaelis LL (1977) Significance of subendocardial S-T segment elevation caused by coronary stenosis in the dog. Epicardial S-T segment depression, local ischemia and subsequent necrosis. Am J Cardiol 40: 373–380
Hackett JG, Abboud FM, Mark AL, Schmid PG, Heistad DD (1972) Coronary vascular responses to stimulation of chemoreceptors and baroreceptors. Circ Res 31: 8–17
Haga Y, Hatori N, Nordlander M, Nordlander R, Sjoequist PO, Ryden L (1993) Coronary venous retroinfusion of felodipine reducing infarct size without affecting regional myocardial blood flow. Eur Heart J 14: 1386–1393
Hagar JM, Hale SL, Kloner RA (1991) Effect of preconditioning ischemia on reperfusion arrhythmias after coronary artery occlusion and reperfusion in the rat. Circ Res 68: 61–68
Hagar JM, Newman LG, Kloner RA (1992) Effects of amlodipine on myocardial infarction, infarct expansion, and ventricular geometry in the rat. Am Heart J 124: 571–580
Hamilton FN, Feigl EO (1976) Coronary vascular sympathetic beta-receptor innervation. Am J Physiol 230: 1569–1576
Harada K, Franklin A, Johnson RG, Grossman W, Morgan JP (1994) Acidemia and hypernatremia enhance postischemic recovery of excitation-contraction coupling. Circ Res 74: 1197–1209
Hart G, Gokal R (1977) The syndrome of inappropriate antidiuretic hormone secretion associated with acute myocardial infarction. Postgrad Med J 53: 761–762
Hatori N, Haga Y, Sjöquist P-O, Nordlander M, Rydén L (1993) Coronary venous retroinfusion of felodipine reduces myocardial necrosis after coronary occlusion and reperfusion. J Cardiovasc Pharmacol 22: 160–166
Hearse DJ (1991) Stunning: a radical re-view. Cardiovasc Drugs Ther 5: 853–876
Hearse DJ, Bolli R (1992) Reperfusion induced injury: manifestations, mechanisms, and clinical relevance. Cardiovasc Res 26: 101–108
Heusch G (1985) Sympathische Herznerven and Myokardischämie. Thieme, Stuttgart, New York
Heusch G (1990) a-Adrenergic mechanisms in myocardial ischemia. Circulation 81:1–13
Heusch G (1991) The relationship between regional blood flow and contractile function in normal, ischemic, and reperfused myocardium. Basic Res Cardiol 86: 197–218
Heusch G (1992) Myocardial stunning: a role for calcium antagonists during ischaemia? Cardiovasc Res 26: 14–19
Heusch G (1994) Ischemia-selectivity: a new concept of cardioprotection by calcium antagonists. Basic Res Cardiol 89: 2–5
Heusch G, Deussen A (1983) The effects of cardiac sympathetic nerve stimulation on the perfusion of stenotic coronary arteries in the dog. Circ Res 53: 8–15
Heusch G, Deussen A (1984) Nifedipine prevents sympathetic vasoconstriction distal to severe coronary stenoses. J Cardiovasc Pharmacol 6: 378–383
Heusch G, Deussen A, Schipke J, Thömer V (1984) a,- and az-adrenoceptor-mediated vasoconstriction of large and small canine coronary arteries in vivo. J Cardiovasc Pharmacol 6:961–968
Heusch G, Deussen A, Schipke J, Thämer V (1986) Adenosine, dipyridamole and isosorbiddinitrate are ineffective to prevent the sympathetic initiation of poststenotic myocardial ischemia. Drug Res 36: 1045–1048
Heusch G, Deussen A, Thämer V (1985) Cardiac sympathetic nerve activity and progressive vasoconstriction distal to coronary stenoses: feed-back aggravation of myocardial ischemia. J Auton Nery Syst 13: 311–326
Heusch G, Frehen D, Kröger K, Schulz R, Thämer V (1988) Integrity of sympathetic neurotransmission in stunned myocardium. J Appl Cardiol 3: 259–272
Heusch G, Guth BD (1990) Koronare Vasomotion bei Myokardischämie. In: Heusch, G (Ed) Pathophysiologie and rationale Pharmakotherapie der Myokardischämie. Steinkopff, Darmstadt, S. 205–223
Heusch G, Guth BD, Seitelberger R, Ross Jr. J (1987) Attenuation of exercise-induced myocardial ischemia in dogs with recruitment of coronary vasodilator reserve by nifedipine. Circulation 75: 482–490
Heusch G, Schäfer S, Kröger K (1988) Recruitment of inotropic reserve in „stunned“ myocardium by the cardiotonic agent AR-L 57. Basic Res Cardiol 83: 602–610
Heusch G, Schipke J, Thämer V (1985) Clonidine prevents the sympathetic initiation and aggravation of poststenotic myocardial ischemia. J Cardiovasc Pharmacol 7: 1176–1182
Heusch G, Yoshimoto N (1983) Effects of cardiac contraction on segmental coronary resistances and collateral perfusion. Int J Microcirc 2: 131–141
Heusch G, Yoshimoto N (1983) Effects of heart rate and perfusion pressure on segmental coronary resistances and collateral perfusion. Pfluegers Arch 397: 284–289
Heyndrickx GR, Baig H, Nellens P, Leusen I, Fishbein MC, Vatner SF (1978) Depression of regional blood flow and wall thickening after brief coronary occlusions. Am J Physiol 234:H653–H659
Heyndrickx GR, Boettcher DH, Vatner SF (1976) Effects of angiotensin, vasopressin, and methoxamine on cardiac function and blood flow distribution in conscious dogs. Am J Physiol231: 1579–1587
Heyndrickx GR, Millard RW, McRitchie RJ, Maroko PR, Vatner SF (1975) Regional myocardial functional and electrophysiological alterations after brief coronary artery occlusion in conscious dogs. J Clin Invest 56: 978–985
Higginson L, Tang A, Knoll G, Calvin J (1991) Effect of intracoronary diltiazem on infarct size and regional myocardial function in the ischemic reperfused canine heart. J Am Coll Cardiol 18: 868–875
Hoff PT, Tamura Y, Lucchesi BR (1989) Cardioprotective effects of amlodipine in the ischemic-reperfused heart. Am J Cardiol 64:1011–116I
Hoffman JIE (1984) Maximal coronary flow and the concept of coronary vascular reserve. Circulation 70: 153–159
Hoffman JIE (1987) Transmural myocardial perfusion. Prog Cardiovasc Dis 29: 429–464
Holt WW, Wendland MF, Derugin N, Wolfe C, Saeed M, Higgins CB (1990) Effects of nicardipine, a calcium antagonist, on myocardial salvage and high energyphosphate stores in reperfused myocardial injury. J Am Coll Cardiol 16: 1736–1744
Holtz J, Busse R, Sommer O, Bassenge E (1987) Dilation of epicardial arteries in conscious dogs induced by angiotensin-converting enzyme inhibition with enalaprilat. J Cardiovasc Pharmacol 9: 348–355
Holtz J, Förstermann U, Pohl U, Giesler M, Bassenge E (1984) Flow-dependent, endothelium-mediated dilation of epicardial coronary arteries in conscious dogs: effects of cyclooxygenase inhibition. J Cardiovasc Pharmacol 6: 1161–1169
Holtz J, Saeed M, Sommer O, Bassenge E (1982) Norepinephrine constricts the canine coronary bed via postsynaptic a2-adrenoceptors. Eur J Pharmacol 82: 199–202
Hossack KF, Brown BG, Stewart DK, Dodge HT (1984) Diltiazem-induced blockade of sympathetically mediated constriction of normal and diseased coronary arteries: lack of epicardial coronary dilatory effect in humans. Circulation 70: 465–471
Ignarro LJ, Byrns RE, Buga GM, Wood KS (1987) Endothelium-derived relaxing factor from pulmonary artery and vein possesses pharmacologic and chemical properties identical to those of nitric oxide radical. Circ Res 61: 866–879
Indolfi C, Ross Jr. J (1993) The role of heart rate in myocardial ischemia and infarction: Implications of myocardial perfusion-contraction matching. Prog Cardiovasc Dis 36: 6174
Ito BR, Tate H, Kobayashi M, Schaper W (1987) Reversibly injured, postischemic canine myocardium retains normal contractile reserve. Circ Res 61: 834–846
Iwamoto T, Miura T, Adachi T, Noto T, Ogawa T, Tsuchida A, Iimura O (1991) Myocardial infarct size-limiting effect of ischemic preconditioning was not attenuated by oxygen free-radical scavengers in the rabbit. Circulation 83: 1015–1022
Janero DR, Burghardt B (1989) Antiperoxidant effects of dihydropyridine calcium antagonists. Biochem Pharmacol 38: 4344–4348
Jennings RB, Schaper J, Hill ML, Steenbergen CJ, Reimer KA (1985) Effect of reperfusion late in the phase of reversible ischemic injury. Changes in cell volume, electrolytes, metabolites, and ultrastructure. Circ Res 56: 262–278
Jeremy RW, Stahl L, Gillinov M, Litt M, Aversano TR, Becker LC (1989) Preservation of coronary flow reserve in stunned myocardium. Am J Physiol 256:H1303–H1310
Jeroudi MO, Triana FJ, Patel BS, Bolli R (1990) Effects of superoxide dismutase and catalase, given separately, on myocardial stunning. Am J Physiol 259:H889–H901
Johannsen UJ, Mark AL, Marcus ML (1982) Responsiveness to cardiac sympathetic nerve stimulation during maximal coronary dilation produced by adenosine. Circ Res 50: 510517
Johansson B, Mellander S (1975) Static and dynamic components in the vascular myogenic response to passive changes in length as revealed by electrical and mechanical recordings from the rat portal vein. Circ Res 36: 76–83
Kambayashi M, Miura T, Oh BH, Murata K, Rockman HA, Parra G, Ross Jr. J (1992) Myocardial cell hypertrophy after myocardial infarction with reperfusion in dogs. Circulation 86: 1935–1944
Karasawa A, Kubo K, Shuto K, Oka T, Nakamizo N (1988) Beneficial effects of the new calcium antagonist benidipine hydrochloride on myocardial dysfunction following coronary occlusion and reperfusion in anesthetized dogs. Drug Res 38: 1717–1721
Kaski JC, Maseri A (1990) Klinische Bedeutung des koronaren Vasomotorentonus bei Myokardischämie. In: Heusch, G (Ed) Pathophysiologie and rationale Pharmakotherapie der Myokardischämie. Steinkopff, Darmstadt. S. 225–238.
Kass RW, Kotler MN, Yazdanfar S (1992) Stimulation of coronary collateral growth: current developments in angiogenesis and future clinical applications. Am Heart J 123: 486496
Katoh N, Wise BC, Kuo JF (1983) Phosphorylation of cardiac troponin inhibitory subunit (troponin I) and tropomyosin-binding subunit (troponin T) by cardiac phospholipid-sensitive Ca’ -dependent protein kinase. Biochem J 209: 189–195
Kazda S, Towart R (1981) Differences in the effects of the calcium antagonist nimodipine (BAY e 9736) and bencyclan on cerebral and peripheral vascular smooth muscle. Br J Pharmacol 72:582P–583P
Kelley KO, Feigl EO (1978) Segmental alpha-receptor-mediated vasoconstriction in the canine coronary circulation. Circ Res 43: 908–917
Kelm M, Schrader J (1988) Nitric oxide release from the isolated guinea pig heart. Eur J Pharmacol 155: 317–321
Kida M, Fujiwara H, Ishida M, Kawai C, Ohura M, Miura I, Yabuuchi Y (1991) Ischemic preconditioning preserves creatine phosphate and intracellular pH. Circulation 84: 24952503
Kida M, Fujiwara H, Uegaito T, Miyamae M, Ohura M, Miura I, Yabuuchi Y (1993) Dobutamine prevents both myocardial stunning and phosphocreatine overshoot without affecting ATP level. J Mol Cell Cardiol 25: 875–885
Kihara Y, Grossman W, Morgan JP (1989) Direct measurement of changes in intracellular calcium transients during hypoxia, ischemia, and reperfusion of the intact mammalian heart. Circ Res 65: 1029–1044
Kitakaze M, Marban E (1989) Cellular mechanism of the modulation of contractile function by coronary perfusion pressure in ferret hearts. J Physiol 414: 455–472
Kitakaze M, Weisfeldt ML, Marban E (1988) Acidosis during early reperfusion prevents myocardial stunning in perfused ferret hearts. J Clin Invest 82: 920–927
Kitakaze M, Weisman HF, Marban E (1988) Contractile dysfunction and ATP depletion after transient calcium overload in perfused ferret hearts. Circulation 77: 685–695
Kjekshus JK (1973) Mechanisms for flow distribution in normal and ischemic myocardium during increased ventricular preload in the dog. Circ Res 33: 489–499
Klein HH, Schubothe M, Nebendahl K, Kreuzer H (1984) The effect of two different diltiazem treatments on infarct size in ischemic, reperfused porcine hearts. Circulation 69: 1000–1005
Klocke FJ (1987) Measurements of coronary flow reserve: defining pathophysiology versus making decisions about patient care. Circulation 76: 1183–1189
Kloner RA, DeBoer LWV, Darsee JR, Ingwall JS, Braunwald E (1981) Recovery from prolonged abnormalities of canine myocardium salvaged from ischemic necrosis by coronary reperfusion. Proc Natl Acad Sci USA 78: 7152–7156
Kloner RA, Shook T, Przyklenk K, Davis VG, Junio L, Matthews RV, Burstein S, Gibson CM, Poole WK, Cannon CP, McCabe CH, Braunwald E (1995) Previous angina alters in-hospital outcome in TIMI 4. A clinical correlate to preconditioning. Circulation 91: 37–47
Kloner RA, Yellon D (1994) Does ischemic preconditioning occur in patients? J Am Coll Cardiol 24: 1133–1142
Knight DR, Shen Y-T, Young MA, Vatner SF (1991) Acetylcholine-induced coronary vasoconstriction and vasodilation in tranquilized baboons. Cire Res 69: 706–713
Kojima S, Wu ST, Watters TA, Parmley WW, Wikman-Coffelt J (1993) Effects of perfusion pressure on intracellular calcium, energetics, and function in perfused rat hearts. Am J Physiol 264: H183–H189
Koller PT, Bergmann SR (1989) Reduction of lipid peroxidation in reperfused isolated rabbit hearts by diltiazem. Circ Res 65: 838–846
Kordenat K, Leasure J (1986) Effect of tiapamil on canine myocardial infarct size. Am Heart J 111: 502–512
Krams R, Duncker DJ, McFalls EO, Hogendoorn A, Verdouw PD (1993) Dobutamine restores the reduced efficiency of energy transfer from total mechanical work to external mechanical work in stunned porcine myocardium. Cardiovasc Res 27: 740–747
Krause S, Hess ML (1984) Characterization of cardiac sarcoplasmic reticulum dysfunction during short-term, normothermic, global ischemia. Circ Res 55: 176–184
Kröger K, Schipke J, Thämer V, Heusch G (1989) Poststenotic ischemic myocardial dysfunction induced by peripheral nociceptive stimulation. Eur Heart J 10 (Suppl.F): 179–182
Kudoh Y, Hearse DJ, Maxwell MP, Yoshida S, Downey JM, Yellon DM (1986) Calcium antagonists and evolving myocardial infarction: studies of the effects of nifedipine on tissue ATP, collateral flow and infarct size in the closed chest dog. J Mol Cell Cardiol 18 (Supp1.4): 77–92
Kuebler W, Strasser RH (1994) Signal tranduction in myocardial ischemia. Eur Heart J 15: 437–445
Kuo L, Chilian WM, Davies MJ (1990) Coronary arteriolar myogenic response is independent of endothelium. Circ Res 66: 860–866
Kusuoka H, Jacobus WE, Marban E (1988) Calcium oscillations in digitalis-induced ventricular fibrillation: Pathogenetic role and metabolic consequences in isolated ferret hearts. Circ Res 62: 609–619
Kusuoka H, Koretsune Y, Chacko VP, Weisfeldt ML, Marban E (1990) Excitation-contraction coupling in postischemic myocardium. Does failure of activator Ca++ transients underlie stunning? Circ Res 66: 1268–1276
Kusuoka H, Porterfield JK, Weisman HF, Weisfeldt ML, Marban E (1987) Pathophysiology and pathogenesis of stunned myocardium: Depressed Cat+ activation of contraction as a consequence of reperfusion-induced cellular calcium overload in ferret hearts. J Clin Invest 79: 950–961
Lamping KA, Christensen CW, Pelc LR, Warltier DC, Gross GJ (1984) Effects of nicorandil and nifedipine on protection of ischemic myocardium. J Cardiovasc Pharmacol 6: 536542
Lamping KA, Gross GJ (1985) Improved recovery of myocardial segment function following a short coronary occlusion in dogs by nicorandil, a potential new antianginal agent, and nifedipine. J Cardiovasc Pharmacol 7: 158–166
Lamping KG, Marcus ML, Dole WP (1985) Removal of the endothelium potentiates canine large coronary artery constrictor responses to 5-hydroxytryptamine in vivo. Circ Res 57: 46–54
Lansman JB, Hallam TJ, Rink TJ (1987) Single stretch-activated ion channels in vascular endothelial cells as mechanotransducers? Nature 325: 811–813
Laxson DD, Homans DC, Dai X-Z, Sublett E, Bache RJ (1989) Oxygen consumption and coronary reactivity in postischemic myocardium. Circ Res 64: 9–20
Lee H-C, Mohabir R, Smith N, Franz MR, Clusin WT (1988) Effect of ischemia on calcium-dependent fluorescence transients in rabbit hearts containing indo 1. Correlation with monophasic action potentials and contraction. Circulation 78: 1047–1059
Lee H-C, Smith N, Mohabir R, Clusin WT (1987) Cytosolic calcium transients from the beating mammalian heart. Proc Natl Acad Sci USA 84: 7793–7797
Lee JA, Allen DG (1992) Changes in intracellular free calcium concentration during long exposures to simulated ischemia in isolated mammalian ventricular muscle. Circ Res 71: 58–69
Levene DL, Freeman MR (1976) a-Adrenoceptor-mediated coronary artery spasm. J Am Med Assoc 236:1018–1022
Li GC, Vasquez JA, Gallagher KP, Lucchesi BR (1990) Myocardial protection with preconditioning. Circulation 82: 609–619
Li XY, McCay PB, Zughaib M, Jeroudi MO, Triana JF, Bolli R (1993) Demonstration of free radical generation in the „stunned“ myocardium in the conscious dog and identification of major differences between conscious and open-chest dogs. J Clin Invest 92: 10251041
Li Y, Kloner RA (1992) Cardioprotective effects of ischaemic preconditioning are not mediated by prostanoids. Cardiovasc Res 26: 226–231
Li Y, Kloner RA (1995) Does protein kinase C play a role in ischemic preconditioning in rat hearts? Am J Physiol 268:H426–H431
Liu GS, Thornton J, van Winkle DM, Stanley AWH, Olsson RA, Downey JM (1991) Protection against infarction afforded by preconditioning is mediated by Al adenosine receptors in rabbit heart. Circulation 84: 350–356
Liu Y, Cohen MV, Downey JM (1994) Chelerythrine, a highly selective protein kinase C inhibitor, blocks the antiinfarct effect of ischemic preconditioning in rabbit hearts. Cardiovase Drugs Ther 8: 881–882
Liu Y, Ytrehus K, Downey JM (1994) Evidence that translocation of protein kinase C is a key event during ischemic preconditioning of rabbit myocardium. J Mol Cell Cardiol 26: 661–668
Lo HM, Kloner RA, Alker KJ, Braunwald E (1985) Effect of intracoronary verapamil on infarct size in the ischemic, reperfused canine heart: critical importance of the timing of treatment. Am J Cardiol 56: 672–677
Lucchesi BR, Hoff PT, Tamura Y (1991) Cardioprotective effects of amlodipine in animal models of ischemia and reperfusion. J Cardiovasc Pharmacol 17 (Supp1.1): S34–S39
Ludmer PL, Selwyn AP, Shook TL, Wayne RR, Mudge GH, Alexander RW, Ganz P (1986) Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. N Engl J Med 315: 1046–1051
Lückhoff A, Busse R (1990) Calcium influx into endothelial cells and formation of endothelium-derived relaxing factor is controlled by the membrane potential. Pfluegers Arch 416: 305–311
Mak IT, Weglicki WB (1990) Comparative antioxidant activities of propranolol, nifedipine, verapamil, and diltiazem against sarcolemmal membrane lipid peroxidation. Circ Res 66: 1449–1452
Marban E (1995) Excitation-contraction coupling in hibernating myocardium. Basic Res Cardiol 90: 19–22
Marban E, Gao WD (1995) Stunned myocardium: a disease of the myofilaments? Basic Res Cardiol 90: 269–272
Marban E, Kitakaze M, Chacko VP, Pike MM (1988) Ca’ transients in perfused hearts revealed by gated ‘8F NMR spectroscopy. Cire Res 63: 673–678
Marban E, Kitakaze M, Kusuoka H, Porterfield JK, Yue DT, Chacko VP (1987) Intracellular free calcium concentration measured with ‘8F NMR spectroscopy in intact ferret hearts. Proc Natl Acad Sci USA 84: 6005–6009
Marcus ML, Wright C, Doty D, Eastham C, Laughlin D, Krumm P, Fastenow C, Brody M (1981) Measurements of coronary velocity and reactive hyperemia in the coronary circulation of humans. Circ Res 49: 877–891
Mark AL, Abboud FM, Schmid PG, Heistad DD, Mayer UJ (1972) Differences in direct effects of adrenergic stimuli on coronary, cutaneous and muscular vessels. J Clin Invest 51: 279–287
Maseri A, Chierchia S (1982) Coronary artery spasm: demonstration, definition, diagnostic, and consequences. Prog Cardiovasc Dis 25: 169–192
Massoudy P, Becker BF, Seligmann C, Gerlach E (1995) Preischaemic as well as postischaemic application of a calcium antagonist affords cardioprotection in the isolated guinea pig heart. Cardiovasc Res 29: 577–582
Matsuzaki M, Gallagher KP, Patritti J, Tajimi T, Kemper WS, White FC, Ross Jr. J (1984) Effects of a calcium-entry blocker (diltiazem) on regional myocardial flow and function during exercise in conscious dogs. Circulation 69: 801–814
Matsuzaki M, Patritti J, Tajimi T, Miller M, Kemper WS, Ross Jr. J (1984) Effects of á-blockade on regional myocardial flow and function during exercise. Am J Physiol 247:H52–H60
McHale PA, Dube GP, Greenfield Jr. JC (1987) Evidence for myogenic vasomotor activity in the coronary circulation. Prog Cardiovasc Dis 30: 139–146
McRaven DR, Mark AL, Abboud FM, Mayer HE (1971) Responses of coronary vessels to adrenergic stimuli. J Clin Invest 50: 773–778
Meils CM, Gross GV, Brooks HL, Warltier DC (1981) Reduction of myocardial infarct size by the calcium antagonist FR7534. Cardiology 68: 146–160
Melin JA, Becker LC, Hutchins GM (1984) Protective effect of early and late treatment with nifedipine during myocardial infarction in the conscious dog. Circulation 69: 131–141
Mercier JC, Lando U, Kanmatsuse K, Ninomiya K, Meerbaum S, Fishbein MC, Swan HJC, Ganz W (1982) Divergent effects of inotropic stimulation on the ischemic and severely depressed reperfused myocardium. Circulation 66: 397–400
Millard RW, Grupp G, Grupp IL, DiSalvo J, DePover A, Schwartz A (1983) Chronotropic, inotropic, and vasodilator actions of diltiazem, nifedipine, and verapamil: a comparative study of physiological responses and membrane receptor activity. Circ Res 52: 29–39
Miller WL, Belardinelli L, Bacchus A, Foley DH, Rubio R, Berne KM (1979) Canine myocardial adenosine and lactate production, oxygen consumption, and coronary blood flow during stellate ganglia stimulation. Circ Res 45: 708–718
Mishra SK, Hermsmeyer K (1994) Inhibition of signal Ca’ in dog coronary arterial vascular muscle cells by Ro 40–5967. J Cardiovasc Pharmacol 24: 1 7
Miura T, Goto M, Urabe K, Endoh A, Shimamoto K, Iimura 0 (1991) Does myocardial stunning contribute to infarct size limitation by ischemic preconditioning? Circulation 84: 2504–2512
Miyauchi T, Yanagisawa M, Tomizawa T, Sugishita Y, Suzuki N, Fujino M, Ajisaka R, Goto K, Masaki T (1989) Increased plasma concentrations of endothelin-1 and big endothelin-1 in acute myocardial infarction. Lancet 2: 53–54
Miyazaki T, Zipes DP (1989) Protection against autonomic denervation follo-wing acute myocardial infarction by preconditioning ischemia. Circ Res 64: 437–448
Mohabir R, Lee H-C, Kurz RW, Clusin WT (1991) Effects of ischemia and hypercarbic acidosis on myocyte calcium transients, contraction, and pH, in perfused rabbit hearts. Circ Res 69: 1525–1537
Mohrman DE, Feigl EO (1978) Competition between sympathetic vasoconstriction and metabolic vasodilation in the canine coronary circulation. Circ Res 42: 79–86
Moncada S, Palmer RMJ, Higgs EA (1989) Biosynthesis of nitric oxide from L-arginine. A pathway for the regulation of cell function and communication. Biochem Pharmacol 38: 1709–1715
Moreyra AE, Gelpi RJ, Mosca SM, Cingolani HE (1994) Chronic administration of nicardipine attenuates myocardial stunning in isolated rabbit hearts. J Mol Cell Cardiol 26: 979984
Mosher P, Ross Jr. J, McFate PA, Shaw RF (1964) Control of coronary blood flow by an autoregulatory mechanism. Circ Res 14: 250–259
Mueller HS, Rao PS, Rao PB, Gory DJ, Mudd JG, Ayres SM (1982) Enhanced transcardiac 1-norepinephrine response during cold pressor test in obstructive coronary artery disease. Am J Cardiol 50: 1223–1228
Mullane K (1992) Myocardial preconditioning. Part of the adenosine revival. Circulation 85: 845–847
Muller JE, Morrison J, Stone PH, Rude RE, Rosner B, Roberts R, Pearle DL, Turi ZG, Schneider JF, Serfas DH, Tate C, Scheiner E, Sobel BE, Hennekens CH, Braunwald E (1984) Nifedipine therapy for patients with threatened and acute myocardial infarction: a randomized, double-blind, placebo-controlled comparison. Circulation 69: 740–747
Murray PA, Belloni FL, Sparks HV (1979) The role of potassium in the metabolic control of coronary vascular resistance of the dog. Circ Res 44: 767–780
Murray PA, Vatner SF (1979) a-Adrenoceptor attenuation of coronary vascular response to severe exercise in the conscious dog. Circ Res 45:654–660
Murry CE, Jennings RB, Reimer KA (1986) Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 74: 1124–1136
Murry CE, Richard VJ, Jennings RB, Reimer KA (1991) Myocardial protection is lost before contractile function recovers from ischemic preconditioning. Am J Physiol 260:H796–H804
Murry CE, Richard VJ, Reimer KA, Jennings RB (1990) Ischemic preconditioning slows energy metabolism and delays ultrastructural damage during a sustained ischemic episode. Circ Res 66: 913–931
Myers ML, Bolli R, Lekich RF, Hartley CJ, Roberts R (1986) N-2-mercaptopropionylglycine improves recovery of myocardial function after reversible regional ischemia. J Am Coll Cardiol 8: 1161–1168
Myers PR, Banitt PF, Guerra R, Harrison DG (1989) Characteristics of canine coronary resistance arteries: importance of endothelium. Am J Physiol 257:H603–H610
Nabel EG, Ganz P, Gordon JB, Alexander RW, Selwyn AP (1988) Dilation of normal and constriction of atherosclerotic coronary arteries caused by the cold pressor test. Circulation 77: 43–52
Nagao T, Matlib MA, Franklin D, Millard RW, Schwartz A (1980) Effects of diltiazem, a calcium antagonist, on regional myocardial function and mitochondria after brief coronary occlusion. J Mol Cell Cardiol 12: 29–43
Nakamura M, Kikuchi Y, Senda Y, Yamada A, Koiwaya Y (1980) Myocardial blood flow following experimental coronary occlusion. Effects of diltiazem. Chest 78:2Q5–209
Nayler WG (1989) Amlodipine pretreatment and the ischemic heart. Am J Cardiol 64: 65170I
Nayler WG (1990) The endothelins. Springer, Berlin, Heidelberg, New York
Nayler WG (1991) The molecular biology of the voltage-dependent, calcium antagonist-sensitive calcium channels. Anonymous second generation of calcium antagonists. Springer, Berlin, Heidelberg, S. 25–37
Nayler WG (1991) Second Generation of Calcium Antagonists. Springer, Berlin, Heidelberg
Nayler WG, Buckley DJ, Leong J (1990) Calcium antagonists and the „stunned“ myocardium. Cardioscience 1: 61–64
Nayler WG, Liu J, Panagiotopoulos S (1990) Nifedipine and experimental cardioprotection. Cardiovasc Drugs Ther 4: 879–886
Nonogi H, Hess OM, Ritter M, Bortone A, Corin WJ, Grimm J, Krayenbuehl HP (1988) Prevention of coronary vasoconstriction by diltiazem during dynamic exercise in patients with coronary artery disease. J Am Coll Cardiol 12: 892–899
Olesen S-P, Clapham DE, Davies PF (1988) Haemodynamic shear stress activates a K current in vascular endothelial cells. Nature 331: 168–170
Olivetti G, Capasso JM, Meggs LG, Sonnenblick EH, Anversa P (1991) Cellular basis of chronic ventricular remodeling after myocardial infarction in rats. Circ Res 68: 856–869
Olivetti G, Capasso JM, Sonnenblick EH, Anversa P (1990) Side-to-side slippage of myocytes participates in ventricular wall remodeling acutely after myocardial infarction in rats. Circ Res 67: 23–24
Ono S, Waldman LK, Yamashita H, Covell JW, Ross Jr. J (1995) Effects of coronary artery reperfusion on transmural myocardial remodeling in dogs. Circulation 91: 1143–1153
Opie LH (1992) Myocardial stunning: a role for calcium antagonists during reperfusion. Cardiovasc Res 26: 19–24
Opie LH (1990) Clinical use of calcium channel antagonist drugs. Kluwer Academic Publishers, Boston, Dordrecht, London
Opie LH (1992) Should calcium antagonists be used after myocardial infarction? Ischemia selectivity versus vascular selectivity. Cardiovasc Drugs Ther 6: 19–24
Osakada G, Kumada T, Gallagher KP, Kemper WS, Ross Jr. J (1981) Reduction of exercise-induced ischemic regional myocardial dysfunction by verapamil in conscious dogs. Am Heart J 101: 707–712
Ottani F, Galvani M, Ferrini D, Sorbello F, Limonetti P, Pantoli D, Rusticali F (1995) Prodromal angina limits infarct size. A role for ischemic preconditioning. Circulation 91: 291–297
Ovize M, Kloner RA, Hale SL, Przyklenk K (1992) Coronary cyclic flow variations „precondition“ ischemic myocardium. Circulation 85: 779–789
Ovize M, Przyklenk K, Hale SL, Kloner RA (1992) Preconditioning does not attenuate myocardial stunning. Circulation 85: 2247–2254
Palmer RMJ, Ferrige AG, Moncada S (1987) Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 327: 524–526
Pantely GA, Bristow JD, Swenson LJ, Ladley HD, Johnson WB, Anselone CG (1985) Incomplete coronary vasodilation during myocardial ischemia in swine. Am J Physiol 249:H638–H647
Pantely GA, Ladley HD, Anselone CG, Bristow JD (1985) Vasopressin-induced coronary constriction at low perfusion pressures. Cardiovasc Res 19: 433–441
Pantely GA, Malone SA, Rhen WS, Anselone CG, Arai A, Bristow J, Bristow JD (1990) Regeneration of myocardial phosphocreatine in pigs despite continued moderate ischemia. Circ Res 67: 1481–1493
Pelc LR, Farber NE, Warltier DC, Gross GJ (1989) Reduction of myocardial ischemiareperfusion injury by KT-362, a new intracellular calcium antagonist in anesthetized dogs. J Cardiovasc Pharmacol 13: 586–593
Pelc LR, Garancis JC, Gross GJ, Warltier DC (1990) Alteration of endothelium-dependent distribution of myocardial blood flow after coronary occlusion and reperfusion. Circulation 81: 1928–1937
Perez-Cao A, Gil-Loyzaga P, Merchan-Perez A, Tamargo J (1994) Effects of oxodipine and nitrendipine on the size of experimental myocardial infarction in the rat. Pharmacol Toxicol 74: 321–329
Peters KG, Marcus ML, Harrison DG (1989) Vasopressin and the mature coronary collateral circulation. Circulation 79: 1324–1331
Pfeffer MA, Braunwald E (1991) Ventricular enlargement following infarction is a modifiable process. Am J Cardiol 68:127D–131D
Pijl AJ, Hendriks MGC, Kam KL, Pfaffendorf M, van Zwieten PA (1994) Antiischemic effects of nifedipine in isolated working heart preparations on healthy, diabetic, and hypertensive rats. J Cardiovasc Pharmacol 23: 379–386
Pip AJ, Pfaffendorf M, Mathy M-J, van Zwieten PA (1993) Cardioprotection by nifedipine in isolated working hearts: a comparative study on three different types of experimental ischemia. J Cardiovasc Pharmacol 21: 70–76
Pohl U, Busse R, Kuon E, Bassenge E (1986) Pulsatile perfusion stimulates the release of endothelial autacoids. J Appl Cardiol 1: 215–235
Pohl U, Holtz J, Busse R, Bassenge E (1986) Crucial role of endothelium in the vasodilator response to increased flow in vivo. Hypertension 8: 37–44
Pouleur H, van Eyll C, Gurne O, Rousseau MF (1992) Effects of prolonged nisoldipine administration on the Hibernating“ myocardium. J Cardiovasc Pharmacol 20 (Suppl.): S73–S78
Preuss KC, Gross GJ, Brooks HL, Warltier DC (1987) Time course of recovery of „stunned“ myocardium following variable periods of ischemia in conscious and anesthetized dogs. Am Heart J 114: 696–703
Przyklenk K, Ghafari GB, Eitzman DT, Kloner RA (1989) Nifedipine administered after reperfusion ablates systolic contractile dysfunction of postischemic „stunned“ myocardium. J Am Coll Cardiol 13: 1176–1183
Przyklenk K, Kloner RA (1988) Effect of verapamil on postischemic „stunned“ myocardium: importance of the timing of treatment. J Am Coll Cardiol 11: 614–623
Przyklenk K, Kloner RA (1992) Letter to the editor: Calcium antagonists and the stunned myocardium: a role during ischemia? A role during reperfusion? Cardiovasc Res 26: 8284
Raff WK, Kosche F, Goebel H, Lochner W (1972) Coronary extravascular resistance at increasing left ventricular pressure. Pfluegers Arch 333: 352–361
Raff WK, Kosche F, Lochner W (1971) Herzfrequenz and extravasale Komponente des Coronarwiderstandes. Pfluegers Arch 323: 241–249
Raff WK, Kosche F, Lochner W (1972) Extravascular coronary resistance and its relation to microcirculation. Am J Cardiol 29: 598–603
Rafflenbeul W (1990) Behandlung der Myokardischämie mit Kalziumantagonisten. In: Heusch, G (Ed) Pathophysiologie and rationale Pharmakotherapie der Myokardischämie. Steinkopff, Darmstadt. S. 309–328
Rafflenbeul W, Lichtlen PR (1982) Zum Konzept der „dynamischen“ Koronarstenose. Z Kardiol 71: 439–444
Rahimtoola SH (1989) The hibernating myocardium. Am Heart J 117: 211–221
Raizner AE, Chahine RA, Ishimori T, Verani MS, Zacca N, Jamal N, Miller RR, Luchi RJ (1980) Provocation of coronary artery spasm by the cold pressor test. Circulation 62: 925932
Rauch B, Richardt G, Barth R, Zimmermann R, Tillmanns H, Schémig A, Kübler W, Neumann FJ (1992) Intracoronary gallopamil during percutaneous transluminal coronary angioplasty. J Cardiovasc Pharmacol 7: S32–S39
Reimer KA, Jennings RB, Cobb FR, Murdock RH, Greenfield Jr. JC, Becker LC, Bulkley BH, Hutchins GM, Schwartz Jr. RP, Bailey KR, Passamani ER (1985) Animal models for protecting ischemic myocardium: results of the NHLBI cooperative study. Comparison of unconscious and conscious dog models. Circ Res 56: 651–665
Reimer KA, Lowe JE, Jennings RB (1977) Effect of calcium antagonist verapamil on necrosis following temporary artery occlusion in dogs. Circulation 55: 581–587
Reimer KA, Lowe JE, Rasmussen MM, Jennings RB (1977) The wavefront phenomenon of ischemic cell death. 1. Myocardial infarct size vs duration of coronary occlusion in dogs. Circulation 56: 786–794
Ribeiro LGT, Cheung WM, Maroko PR (1982) Influence of the extent of the zone at risk on the effectiveness of drugs in reducing infarct size. Circulation 66: 181–186
Ribeiro LGT, Yasuda T, Lowenstein E, Braunwald E, Maroko PR (1979) Comparative effects on anatomic infarct size of verapamil, ibuprofen, and morphine-promethazine-chlorpromazine combination. Am J Cardiol 43: 396
Robertson RM, Bernard YD, Carr RK, Robertson D (1983) Alpha-adrenergic blockade in vasotonic angina: lack of efficacy of specific alpha,-receptor blockade with prazosin. J Am Coll Cardiol 2: 1146–1150
Rohmann S, Schott RJ, Harting J, Schaper W (1991) Ischemic preconditioning is not a function of stunned myocardium. J Mol Cell Cardiol 23 (Suppl.V): 71 (Abstract)
Rooke GA, Feigl EO (1982) Work as a correlate of canine left ventricular oxygen consumption, and the problem of catecholamine oxygen wasting. Circ Res 50: 273–286
Ross Jr. J (1993) Left ventricular function after coronary artery reperfusion. Am J Cardiol 72: 91 G-97G
Rouleau J, Boerboom LE, Surjadhana A, Hoffman JIE (1979) The role of autoregulation and tissue diastolic pressures in the transmural distribution of left ventricular blood flow in anesthetized dogs. Circ Res 45: 804–815
Rousseau G, Provost P, Latour J-G (1993) Sustained myocardial protection by clentiazem (TA-3090) after 90-minute coronary occlusion and 72 hours of reperfusion in dogs with collateral flow. J Cardiovasc Pharmacol 22: 264–272
Rousseau G, Provost P, Tran D, Caillé G, Latour J-G (1994) Clentiazem given at reperfusion improves subendocardial reflow and reduces myocardial infarct size in the dog. J Pharmacol Exp Ther 268: 1252–1260
Rousseau G, St-Jean G, Latour J-G, Merhi Y, Nattel S, Waters D (1991) Diltiazem at reperfusion reduces neutrophil accumulation and infarct size in dogs with ischaemic myocardium. Cardiovasc Res 25: 319–329
Rowe GG (1970) Inequalities of myocardial perfusion in coronary artery disease („coronary steal“). Circulation 42: 193–194
Rudolph W, Reiniger G, Dirschinger J, Kraus F (1990) Behandlung der Myokardischämie mit Nitraten. In: Heusch, G (Ed) Pathophysiologie and rationale Pharmakotherapie der Myokardischämie. Steinkopff, Darmstadt, S. 289–307.
Sanguinetti MC, Kass RS (1984) Voltage-dependent block of calcium channel current in the calf cardiac Purkinje fiber by dihydropyridine calcium channel antagonists. Circ Res 55: 336–348
Sasayama S, Fujita M (1992) Recent insights into coronary collateral circulation. Circulation 85: 1197–1204
Schaper W (1993) New paradigms for collateral vessel growth. Basic Res Cardiol 88: 193198
Schaper W, Gorge G, Winkler B, Schaper J (1988) The collateral circulation of the heart. Prog Cardiovasc Dis 31: 57–77
Schäfer S, Heusch G (1990) Recruitment of a time-dependent inotropic reserve by postextrasystolic potentiation in normal and reperfused myocardium. Basic Res Cardiol 85: 257269
Schäfer S, Linder C, Heusch G (1990) Xamoterol recruits an inotropic reserve in the acutely failing, reperfused canine myocardium without detrimental effects on its subsequent recovery. Naunyn Schmiedebergs Arch Pharmacol 342: 206–213
Schipke J, Heusch G, Deussen A, Thämer V (1985) Acetylcholine induces constriction of epicardial coronary arteries in anesthetized dogs after removal of endothelium. Drug Res 35: 926–929
Schulz R, Guth BD, Heusch G (1991) No effect of coronary perfusion on regional myocardial function within the autoregulatory range in pigs: Evidence against the Gregg phenomenon. Circulation 83: 1390–1403
Schulz R, Guth BD, Pieper K, Martin C, Heusch G (1992) Recruitment of an inotropic reserve in moderately ischemic myocardium at the expense of metabolic recovery: a model of short-term hibernation. Circ Res 70: 1282–1295
Schulz R, Janssen F, Guth BD, Heusch G (1991) Effect of coronary hyperperfusion on regional myocardial function and oxygen consumption of stunned myocardium in pigs. Basic Res Cardiol 86: 534–543
Schulz R, Rose J, Heusch G (1994) Involvement of activation of ATP-dependent potassium channels in ischemic preconditioning in swine. Am J Physiol 267:H1341–H1352
Schulz R, Rose J, Martin C, Brodde 0E, Heusch G (1993) Development of short-term myocardial hibernation: its limitation by the severity of ischemia and inotropic stimulation. Circulation 88: 684–695
Schulz R, Rose J, Post H, Heusch G (1995) Involvement of endogenous adenosine in ischemic preconditioning in swine. Pflügers Archiv 430: 273–282
Schwartz JS, Carlyle PF, Cohn JN (1980) Effect of coronary arterial pressure on coronary stenosis resistance. Circulation 61: 70–76
Seitelberger R, Guth BD, Heusch G, Lee JD, Katayama K, Ross Jr. J (1988) Intracoronary alpha2- adrenergic receptor blockade attenuates ischemia in conscious dogs during exercise. Circ Res 62: 436–442
Sekili S, McCay PB, Li X-Y, Zughaib M, Sun J-Z, Tang L, Thornby JL, Bolli R (1993) Direct evidence that the hydroxyl radical plays a pathogenetic role in myocardial „stunning“ in the conscious dog and demonstration that stunning can be markedly attenuated without subsequent adverse effects. Circ Res 73: 705–723
Selwyn AP, Welman E, Fox K, Horlock P, Pratt T, Klein M (1979) The effects of nifedipine on acute experimental myocardial ischemia and infarction in dogs. Circ Res 44: 16–23
Shiki K, Hearse DJ (1987) Preconditioning of ischemic myocardium: reperfusion-induced arrhythmias. Am J Physiol 253: H1470–H1476
Simmet T, Peskar BA (1986) Eicosanoids and the coronary circulation. Rev Physiol Biochem Pharmacol 104: 1–64
Sirnes PA, Overskeid K, Pedersen TR, Bathen J, Drivenes A, Froland GS, Kiekshus JK, Landmark K, Rokseth R, Sirnes KE, Sundoy A, Torjussen BR, Westlund KM, Wik BA (1984) Evolution of infarct size during the early use of nifedipine in patients with acute myocardial infarction: The Norwegian Nifedipine Multicenter Trial. Circulation 70: 638644
Somlyo AP, Somlyo AV (1994) Signal transduction and regulation in smooth muscle. Nature 372: 231–236
Somlyo AV, Bond M, Somlyo AP, Scarpa A (1985) Inositol trisphosphate—induced calcium release and contracion in vascular smooth muscle. Proc Natl Acad Sci USA 82: 52315235
Speechly-Dick ME, Mocanu MM, Yellon DM (1994) Protein Cinase C. Its role in ischemic preconditioning in the rat. Circ Res 75: 586–590
Stahl LD, Aversano TR, Becker LC (1986) Selective enhancement of function of stunned myocardium by increased flow. Circulation 74: 843–851
Steenbergen C, Hill ML, Jennings RB (1987) Cytoskeletal damage during myocardial ischemia: Changes in vinculin immunofluorescence staining during total in vitro ischemia in canine hearts. Circ Res 60: 478–486
Steenbergen C, Murphy E, Levy L, London RE (1987) Elevation in cytosolic free calcium concentration early in myocardial ischemia in perfused rat heart. Circ Res 60: 700–707
Steenbergen C, Perlman ME, London RE, Murphy E (1993) Mechanism of preconditioning. Ionic alterations. Circ Res 72: 112–125
Sullivan AT, Baker DJ, Drew GM (1991) Effect of calcium channel blocking agents on infarct size after ischaemia-reperfusion in anaesthetised pigs: relationship between cardioprotection and cardiodepression. J Cardiovasc Pharmacol 17: 707–717
Tani M, Neely JR (1989) Role of intracellular Na+ in Ca’ overload and depressed recovery of ventricular function of reperfused ischemic rat hearts. Circ Res 65: 1045–1056
Taylor AL, Golino P, Eckels R, Pastor P, Buja M, Willerson JT (1990) Differential enhancement of postischemic segmental systolic thickening by diltiazem. J Am Coll Cardiol 15: 737–747
Thadani U, Zellner SR, Glasser S, Bittar N, Montoro R, Miller AB, Chaitman B, Schulman P, Stahl A, DiBianco R, Bray J, Means WE, Morledge J, Coinvestigators (1991) Double-blind, dose-response, placebo-controlled multicenter study of nisoldipine. A new second-generation calcium channel blocker in angina pectoris. Circulation 84: 2398–2408
Thaulow E, Guth BD, Heusch G, Gilpin E, Schulz R, Kröger K, Ross Jr. J (1989) Characteristics of regional myocardial stunning after exercise in dogs with chronic coronary steno-sis. Am J Physiol 257:H113–H119
The Danish Study Group on Verapamil in Myocardial Infarction (1984) Verapamil in acute myocardial infarction. Eur Heart J 5: 516–528
The Danish Study Group on Verapamil in Myocardial Infarction (1990) Effect of verapamil on mortality and major events after acute myocardial infarction (the Danish Verapamil Infarction Trial II-DAVIT II). Am J Cardiol 66: 779–785
Thornton J, Striplin S, Liu GS, Swafford A, Stanley AWH, van Winkle DM, Downey JM (1990) Inhibition of protein synthesis does not block myocardial protection afforded by preconditioning. Am J Physiol 259:H1822–H1825
Thornton JD, Liu GS, Olsson RA, Downey JM (1992) Intravenous pretreatment with A,-selective adenosine analogues protects the heart against infarction. Circulation 85: 659–665
Thuesen L, Jorgenson JR, Kvistgaard HJ, Sorensen JA, Vaeth M, Jensen EB, Jensen JJ, Hagerup L (1983) Effect of verapamil on enzyme release after early intravenous administration in acute myocardial infarction: double-blind randomized trial. Br Med J 286: 1107–1108
Tillmanns H, Neumann FJ, Parekh N, Dussel R, Zimmermann R, Dorigo O, Tiefenbacher C, Steinhausen M (1988) Unterschiedliche Wirkung von Koronardilatatoren auf die terminale Strombahn des ischämischen Myokards. Z Kardiol 77 (Suppl. I): 147 (Abstract)
Topol EJ, Ellis SG (1991) Coronary collaterals revisited. Accessory pathway to myocardial preservation during infarction. Circulation 83: 1084–1086
Tölle TR, Schipke JD, Schulz R, Thämer V, Haase J (1986) The nociceptive stimulation induced myocardial ischemia is prevented by fentanyl. Neurosci Lett (Suppl. 26 ): 522 (Abstract)
Triana JF, Li X-Y, Jamaluddin U, Thornby JI, Bolli R (1991) Postischemic myocardial „stunning“: Identification of major differences between the open-chest and the conscious dog and evaluation of the oxygen radical hypothesis in the conscious dog. Circ Res 69: 731–747
Tumas J, Deth R, Kloner RA (1985) Effects of nisoldipine, a new calcium antagonist, on myocardial infarct size and cardiac dynamics following acute myocardial infarction. J Cardiovasc Pharmacol 7: 361–367
Turrens JF, Thornton J, Barnard ML, Snyder S, Liu G, Downey JM (1992) Protection from reperfusion injury by preconditioning hearts does not involve increase antioxidant defenses. Am J Physiol 262:H585–H589
Tzivoni D, Keren A, Benhorin J, Gottlieb S, Atlas D, Stern S (1983) Prazosin therapy for refractory variant angina. Am Heart J 105: 262–266
Ueeda M, Silvia SK, Olsson RA (1992) Nitric oxide modulates coronary autoregulation in the guinea pig. Circ Res 70: 1296–1303
Van Amsterdam FT, Punt NC, Haas M, Zaagsma J (1990) Calcium antagonists show two modes of protection in ischemic heart failure. J Pharmacol Exp Ther 253: 277–283
Van Winkle DM, Feigl EO (1989) Acetylcholine causes coronary vasodilation in dogs and baboons. Circ Res 65: 1580–1593
Van der Elst L, Chatelain P, Manning AS, Laruel R, Haverbeke YV, Muller RN (1994) P nuclear magnetic resonance study of the effects of the calcium ion channel antagonist fantofarone on the rat heart. Eur J Pharmacol 251: 163–172
Van der Heide RS, Schwartz LM, Reimer KA (1994) The novel calcium antagonist Ro 40–5967 limits myocardial infarct size in the dog. Cardiovasc Res 28: 1526–1532
Vatner DE, Knight DR, Homcy CJ, Vatner SF, Young MA (1986) Subtypes of ß-adrenergic receptors in bovine coronary arteries. Circ Res 59: 463–473
Vatner SF (1980) Correlation between acute reductions in myocardial blood flow and function in conscious dogs. Circ Res 47: 201–207
Vatner SF, Hintze TH (1982) Effects of a calcium-channel antagonist on large and small coronary arteries in conscious dogs. Circulation 66: 579–588
Vatner SF, Hintze TH, Macho P (1982) Regulation of large coronary arteries by ß-adrenergic mechanisms in the conscious dog. Circ Res 51: 56–66
Vatner SF, Patrick TA, Knight DR, Manders WT, Fallon JT (1988) Effects of calcium channel blocker on responses of blood flow, function, arrhythmias, and extent of infarction following reperfusion in conscious baboons. Circ Res 62: 105–115
Veniant M, Clozel JP, Hess P, Wolfgang R (1991) Hemodynamic profile of Ro 40–5967 in conscious rats: Comparison with diltiazem, verapamil, and amlodipine. J Cardiovasc Pharmacol 18 (Supp1.10): S 55—S 58
Verdouw PD, Wolffenbuttel BHR, Ten Cate FJ (1983) Nifedipine with and without propranolol in the treatment of myocardial ischemia: effect on ventricular arrhythmias and recovery of regional wall function. Eur Heart J 4 (Suppl.C): 101–1, 08
Villari B, Ambrosio G, Golino P, Ragni M, Focaccio A, Tritto I, Salvatore M, Chiariello M (1993) The effects of calcium channel antagonist treatment and oxygen radical scavenging on infarct size and the no-reflow phenomenon in reperfused hearts. Am Heart J 125: 11–23
Vita JA, Treasure CB, Nabel EG, McLenachan JM, Fish RD, Yeung AC, Vekshtein VI, Selwyn AP, Ganz P (1990) Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease. Circulation 81: 491–497
Vita JA, Treasure CB, Yeung AC, Vekshtein VI, Fantasia GM, Fish RD, Ganz P, Selwyn AP (1992) Patients with evidence of coronary endothelial dysfunction as assessed by acetylcholine infusion demonstrate marked increase in sensitivity to constrictor effects of catecholamines. Circulation 85: 1390–1397
Warltier DC, Gross GJ, Brooks HL, Preuss KC (1988) Improvement of postischemic, contractile function by the calcium channel blocking agent nitrendipine in conscious dogs. J Cardiovasc Pharmacol 12 (Supp1.4): S120–S124
Weintraub WS, Akizuki S, Agarwal JB, Bodenheimer MM, Banka VS, Helfant RH (1982) Comparative effects of nitroglycerin and nifedipine on myocardial blood flow and contraction during flow-limiting coronary stenosis in the dog. Am J Cardiol 50: 281–288
Weintraub WS, Hattori S, Akizuki S, Agarwal JB, Bodenheimer MM, Banka VS, Helfant RH (1984) Influence of nifedipine on collateral blood flow during acute ischemia in the dog. J Am Coll Cardiol 3: 334–340
Weisman HF, Bush DE, Manisi JA, Weisfeldt ML, Healy BH (1988) Cellular mechanisms of myocardial infarct expansion. Circulation 78: 186–201
Weisman HF, Bush DE, Mannisi JA, Bulkley BH (1985) Global cardiac remodeling after acute myocardial infarction. A study in the rat model. J Am Coll Cardiol 5: 1355–1362
Whalen DA, Hamilton DG, Ganote CE, Jennings RB (1974) Effect of a transient period of ischemia on myocardial cells. I: effects of cell volume regulation. Am J Pathol 74: 381398
Wikman-Coffelt J, Wu ST, Parmley WW (1991) Intracellular endocardial calcium and myocardial function in rat hearts. Cell Calcium 12: 39–50
Willerson JT, Scales F, Mukherjee A, Platt M, Templeton GH, Fink GS, Buja LM (1977) Abnormal myocardial fluid retention as an early manifestation of ischemic injury. Am J Pathol 87: 159–188
Winniford MD, Filipchuk N, Hillis LD (1983) Alpha-adrenergic blockade for variant angina: a long-term, double-blind, randomized trial. Circulation 67: 1185–1188
Yanagisawa M, Masaki T (1989) Endothelin, a novel endothelium-derived peptide. Pharmacological activities, regulation and possible roles in cardiovascular control. Biochem Pharmacol 38: 1877–1883
Yasue H, Touyama M, Kato H, Tanaka S, Akiyama F (1976) Prinzmetal’s variant form of angina as a manifestation of alpha-adrenergic receptor-mediated coronary artery spasm: documentation by coronary arteriography. Am Heart J 91: 148–155
Yellon DM, Hearse DJ, Maxwell MP, Chambers DE, Downey JM (1983) Substained limitation of myocardial necrosis 24 hours after coronary artery occlusion: verapamil infusion in dogs with small myocardial infarcts. Am J Cardiol 51: 1409–1413
Yoshida S, Downey JM, Friedman FR, Chambers DE, Hearse DJ, Yellon DM (1985) Nifedipine limits infarct size for 24 hours in closed chest coronary embolized dogs. Basic Res Cardiol 80: 76–87
Young MA, Knight DR, Vatner SF (1987) Autonomic control of large coronary arteries and resistance vessels. Prog Cardiovasc Dis 30: 211–234
Ytrehus K, Liu Y, Downey JM (1994) Preconditioning protects ischemic rabbit heart by protein kinase C acitivation. Am J Physiol 266:H1145–H1152
Zalewski A, Faria DB, Cheung WM, Ribeiro LGT, Maroko PR (1982) Comparative effects of five calcium antagonists on infarct size and mortality after coronary occlusion. Circulation 66 (Suppl.II): 11–66
Zeiher AM, Drexler H, Wollschläger H, Saurbier B, Just H (1989) Coronary vasomotion in response to sympathetic stimulation in humans: importance of the functional integrity of the endothelium. J Am Coll Cardiol 14: 1181–1190
Zeiher AM, Drexler H, Wollschläger H, Just H (1991) Modulation of coronary vasomotor tone in humans. Progressive endothelial dysfunction with different early stages of coronary atherosclerosis. Circulation 83: 391–401
Zucker IH, Cornish KG, Hackley J, Bliss K (1987) Effects of left ventricular receptor stimulation on coronary blood flow in conscious dogs. Circ Res 61 (Suppl. II): 1154–1160
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Dr. Dietrich Steinkopff Verlag, GmbH & Co. KG, Darmstadt
About this chapter
Cite this chapter
Ehring, T., Heusch, G. (1996). Calciumantagonisten bei experimenteller Myokardischämie und Reperfusion. In: Kübler, W., Tritthart, H.A. (eds) Calciumantagonisten. Steinkopff. https://doi.org/10.1007/978-3-642-93678-4_4
Download citation
DOI: https://doi.org/10.1007/978-3-642-93678-4_4
Publisher Name: Steinkopff
Print ISBN: 978-3-642-93679-1
Online ISBN: 978-3-642-93678-4
eBook Packages: Springer Book Archive